Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10719974 | 0.98 | RECQL (0.47) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL3295977 | 0.86 | RECQL (0.57) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL31142149 | 0.81 | RECQL (0.49) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL9154782 | 0.81 | GAA (0.52) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL9154314 | 0.81 | GAA (0.52) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL77511 | 0.80 | RECQL (0.55) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL6559797 | 0.80 | GAA (0.53) | RECQLPOLBGAAEZH2HTT | |
| SCHEMBL3422383 | 0.79 | RECQL (0.50) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL6559770 | 0.79 | POLB (0.33) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL9420237 | 0.79 | GAA (0.48) | RECQLPOLBGAAALDH1A1EZH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743439-A1 | IONIC ORGANIC COMPOUNDS, COMPOSITIONS AND ELECTROLYTES COMPRISING SAME, AND USE THEREOF IN ELECTROCHEMISTRY | Hydro-Québec (CA) | 2026-05-20 | — | — | EP | claimed |
| EP-4713382-A1 | UNSATURATED POLYMER ELECTROLYTES, AND METHODS FOR PRODUCING AND USING SAME IN ELECTROCHEMICAL APPLICATIONS | HYDRO-QUEBEC (CA) | 2026-03-25 | — | — | EP | claimed |
| US-20250382296-A1 | NITROGEN-CONTAINING FUSED THREE RING PRMT5 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | ABBISKO THERAPEUTICS CO LTD (CN) | 2025-12-18 | — | — | US | claimed |
| US-20250320202-A1 | PRMT5 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | ABBISKO THERAPEUTICS CO LTD (CN) | 2025-10-16 | — | — | US | claimed |
| EP-4567036-A1 | NITROGEN-CONTAINING FUSED THREE RING PRMT5 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | Abbisko Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | claimed |
| CN-118650495-B | Weld joint polishing method and polishing equipment based on laser vision | 芜湖行健智能机器人有限公司 | 2025-06-03 | — | — | CN | claimed |
| EP-4556473-A1 | PRMT5 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | Abbisko Therapeutics Co., Ltd. (CN) | 2025-05-21 | — | — | EP | claimed |
| US-20250079513-A1 | SOLID ELECTROLYTES COMPRISING AN IONIC BIFUNCTIONAL MOLECULE, AND USE THEREOF IN ELECTROCHEMISTRY | HYDRO-QUéBEC (CA) | 2025-03-06 | — | — | US | claimed |
| WO-2025030241-A1 | COATING MATERIALS BASED ON FUNCTIONALIZED ORGANIC MOLECULES AND USES THEREOF IN ELECTROCHEMICAL APPLICATIONS | HYDRO-QUéBEC (CA) | 2025-02-13 | — | — | WO | claimed |
| WO-2025030242-A1 | HYDROGEN SULFIDE TRAPPING COMPOUNDS, COMPOSITIONS COMPRISING SAME AND USES THEREOF | HYDRO-QUéBEC (CA) | 2025-02-13 | — | — | WO | claimed |
| JP-4298915-B2 | — | — | 2009-07-22 | — | — | JP | claimed |
| EP-1118632-B1 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORP (JP) | 2005-04-13 | — | — | EP | claimed |
| EP-1058698-B1 | PREPARATION FOR PREVENTION AND HEALING OF INFLAMMATION AFFECTIONS | USTAV MAKROMOLEKULARNI CHEMIE (CZ) | 2004-07-28 | — | — | EP | claimed |
| US-6541114-B2 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORPORATION (JP) | 2003-04-01 | — | — | US | claimed |
| JP-2001525340-A | — | — | 2001-12-11 | — | — | JP | claimed |
| US-20010033932-A1 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORPORATION (JP) | 2001-10-25 | — | — | US | claimed |
| EP-1118632-A2 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR Corporation (JP) | 2001-07-25 | — | — | EP | claimed |
| EP-1058698-A1 | PREPARATION FOR PREVENTION AND HEALING OF INFLAMMATION AFFECTIONS | USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) | 2000-12-13 | — | — | EP | claimed |
| WO-1999028359-A1 | PREPARATION FOR PREVENTION AND HEALING OF INFLAMMATION AFFECTIONS | ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VED C^¿ESKÉ REPUBLIKY (CZ) | 1999-06-10 | — | — | WO | claimed |
| US-5026742-A | Containing dihydroxy (meth)acrylate and tertiary amine compound | BASF AKTIENGESELLSCHAFT (DE) | 1991-06-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382296-A1 | NITROGEN-CONTAINING FUSED THREE RING PRMT5 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | PRMT5, PRMT1, PRMT8 | RECQL 2573/4885POLB 1984/4885GAA 4300/4885 |
| US-20250320202-A1 | PRMT5 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | PRMT5, PRMT1, PRMT8 | RECQL 2397/4885POLB 2242/4885GAA 3556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.